Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: University of California-Davis: Immunoassays for Human and Environmental Health Monitoring

Superfund Research Program

Immunoassays for Human and Environmental Health Monitoring

Project Leader: Natalia Vasylieva
Co-Investigator: Shirley J. Gee
Grant Number: P42ES004699
Funding Period: 1995-2022
View this project in the NIH Research Portfolio Online Reporting Tools (RePORT)

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Facebook page

Progress Reports

Year:   2019  2018  2017  2016  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2001  2000  1999  1998  1997  1996  1995 

Over last funding cycle, the Immunoassays for Human and Environmental Health Monitoring Project has been actively working on preparing the reagents for new cycle of llama immunization to produce nanobodies to five targets of interest identified by the following Projects: Optimizing Bioremediation for Risk Reduction Using Integrated Bioassay, Non-Target Analysis and Genomic Mining Techniques, Critical Role of Mitochondrial Oxidative Stress (MOS) in Chemical Induced Cardiac Toxicity, and Monitoring Endoplasmic Reticulum Stress Caused by Chronic Exposure to Chemicals. The immunization is ongoing, and the preliminary results look promising. Several new formats of immunoassay have been proposed and tested giving excellent results in sensitivity, and also providing rapid screening tools.

Back
to Top